TL;DR: The brain fog many women experience during perimenopause is not imagined — it reflects measurable changes in brain metabolism driven primarily by fluctuating and declining estrogen. Estrogen regulates cerebral glucose uptake, acetylcholine synthesis, and BDNF production, so when levels become erratic, cognition suffers. Dietary strategies that stabilise blood sugar, supply phytoestrogens, reduce neuroinflammation with omega-3 fatty acids, and address common nutrient gaps (vitamin D, magnesium, B vitamins) can meaningfully improve mental clarity. The Mediterranean diet pattern has the strongest overall evidence base for menopausal brain health, and supporting the gut microbiome’s estrogen-recycling capacity adds another layer of protection.

Introduction

Somewhere between the ages of 40 and 55, many women encounter a cognitive shift that feels genuinely alarming. Words that once came effortlessly now hover just out of reach. Concentration fragments without warning. A task that would normally take 20 minutes stretches to an hour. The experience is so consistent across women in perimenopause that researchers have given it formal attention — and what they have found validates what millions of women have been reporting for decades.

Perimenopause brain fog is not a character flaw, a sign of early dementia, or a product of stress alone (though stress certainly compounds it). It is a neurobiological event driven by the same hormonal shifts that cause hot flashes, sleep disruption, and mood changes. The central player is estrogen — specifically, the wild fluctuations and eventual decline in estradiol that define the menopausal transition.

The encouraging finding from recent research is that this cognitive disruption is, for most women, temporary and modifiable. While hormone replacement therapy (HRT) is one approach, dietary strategies offer a complementary — and for some women, primary — line of defence. This article examines why perimenopause affects cognition, which dietary interventions have the strongest evidence, and how to build a practical eating framework around them.

Why Estrogen Matters for the Brain

To understand perimenopause brain fog, you need to understand what estrogen actually does in the central nervous system. It is not merely a reproductive hormone — it is a potent neuromodulator with far-reaching effects on brain function.

Cerebral Glucose Metabolism

The brain runs almost exclusively on glucose, consuming roughly 20% of the body’s total supply. Estrogen directly regulates the expression and activity of glucose transporters in the brain, particularly GLUT1 and GLUT3. When estrogen levels drop, glucose uptake in the brain decreases measurably.

Lisa Mosconi’s neuroimaging research at Weill Cornell Medicine has provided some of the most striking visual evidence of this process. Using FDG-PET scans, Mosconi et al. (2017) showed that perimenopausal and postmenopausal women had significantly reduced cerebral glucose metabolism compared to premenopausal women — reductions of 20 to 30% in key regions including the frontal cortex, temporal cortex, and posterior cingulate. These are not subtle differences. They represent a brain that is, in metabolic terms, running on a diminished fuel supply.

Acetylcholine and Memory

Estrogen promotes the synthesis and release of acetylcholine, the neurotransmitter most directly involved in memory formation, attention, and learning. It does this by upregulating choline acetyltransferase (ChAT), the enzyme that produces acetylcholine, particularly in the hippocampus and basal forebrain (McEwen & Alves, 1999). When estrogen fluctuates unpredictably during perimenopause, acetylcholine production becomes inconsistent — explaining the characteristic “good days and bad days” that many women describe.

BDNF and Neuroplasticity

Brain-derived neurotrophic factor (BDNF) is the brain’s primary growth factor, essential for synaptic plasticity, new neuron survival, and long-term memory consolidation. Estrogen is a potent stimulator of BDNF expression (Scharfman & MacLusky, 2006). Declining estrogen during perimenopause reduces BDNF availability, which impairs the brain’s ability to form new connections and adapt — the neural basis of flexible, sharp thinking.

Neuroinflammation

Estrogen has well-documented anti-inflammatory properties in the brain. It suppresses microglial activation and reduces the production of pro-inflammatory cytokines such as IL-1-beta and TNF-alpha. As estrogen levels fall, the brain’s inflammatory tone rises, creating a low-grade neuroinflammatory state that further impairs cognitive function (Vegeto et al., 2008). This is particularly relevant because neuroinflammation is also a key driver of age-related cognitive decline and neurodegenerative disease — perimenopause may accelerate this trajectory if left unaddressed.

The Cognitive Timeline of Perimenopause

The Study of Women’s Health Across the Nation (SWAN), one of the largest and longest-running studies of the menopausal transition, has tracked cognitive function in over 2,300 women for more than two decades. Its findings are both sobering and reassuring.

Greendale et al. (2009) reported that women in the late perimenopausal stage showed significant declines in processing speed and verbal memory compared to premenopausal women. Critically, these deficits were most pronounced during the transition itself and partially recovered in the postmenopausal years. This suggests that perimenopause brain fog is, for most women, a transient disruption rather than an irreversible decline — though the duration of “transient” can span several years.

The SWAN data also revealed that the severity of cognitive symptoms was influenced by modifiable factors including sleep quality, depressive symptoms, cardiovascular risk factors, and — notably — metabolic health. Women with better insulin sensitivity and lower inflammatory markers experienced milder cognitive disruption during the transition.

Phytoestrogens: Can Plant Compounds Fill the Gap?

Phytoestrogens are plant-derived compounds that structurally resemble estradiol and can bind to estrogen receptors, exerting weak estrogenic effects. The three main classes are isoflavones (found primarily in soy), lignans (found in flaxseeds, sesame seeds, and whole grains), and coumestans (found in legumes and alfalfa sprouts).

Soy Isoflavones and Cognition

The most studied phytoestrogens for cognitive outcomes are soy isoflavones — genistein and daidzein. Epidemiological data from Asian populations, where soy consumption is substantially higher than in Western diets, has long suggested a cognitive benefit. Hogervorst et al. (2008) reported that higher tofu consumption among elderly Indonesian women was associated with better memory performance.

A meta-analysis by Cheng et al. (2015), published in The Journal of the North American Menopause Society, pooled data from 10 randomised controlled trials examining soy isoflavone supplementation in menopausal women. The analysis found a significant overall improvement in cognitive function, with the strongest effects observed for visual memory and executive function. The effective doses ranged from 60 to 160 mg of isoflavones per day — roughly equivalent to two to three servings of traditional soy foods.

However, the evidence is not without caveats. The ability to derive cognitive benefits from soy isoflavones depends partly on the gut microbiome’s capacity to convert daidzein to equol, its more bioactive metabolite. Approximately 30 to 50% of Western populations are “equol producers,” compared to 50 to 70% of Asian populations — a difference likely attributable to long-term dietary patterns and gut microbial ecology (Setchell et al., 2002). This may partially explain why some trials in Western women have shown weaker effects.

Practical Soy Strategy

Whole and minimally processed soy foods are preferable to isolated isoflavone supplements. Good sources include:

  • Edamame (whole soybeans)
  • Tofu (firm or silken)
  • Tempeh (fermented soy, which also provides probiotic benefits)
  • Miso (fermented soy paste)
  • Soy milk (choose unsweetened varieties)

Aim for one to two servings of soy foods daily. Fermented soy products such as tempeh and miso may offer additional advantages because fermentation increases isoflavone bioavailability and supports the gut bacteria involved in equol production.

Omega-3 Fatty Acids and Neuroinflammation

The anti-inflammatory properties of long-chain omega-3 fatty acids — EPA and DHA — are particularly relevant during perimenopause, when declining estrogen removes a key brake on neuroinflammation.

DHA constitutes approximately 40% of the polyunsaturated fatty acids in brain cell membranes, where it maintains membrane fluidity, supports synaptic signalling, and serves as a precursor for specialised pro-resolving mediators (SPMs) that actively resolve inflammatory processes. For a comprehensive look at dosing and sources, see our omega-3 and brain health guide. EPA, while less concentrated in the brain itself, is a potent systemic anti-inflammatory agent.

A study by Dacks et al. (2013) specifically examined omega-3 supplementation in the context of menopausal cognitive decline. They found that DHA supplementation improved verbal fluency and memory consolidation in postmenopausal women, with the most pronounced benefits in women who were not on HRT — suggesting that omega-3s may partially compensate for the loss of estrogen’s anti-inflammatory protection.

The OmegAD trial (Freund-Levi et al., 2006) demonstrated that omega-3 supplementation slowed cognitive decline in patients with mild Alzheimer’s disease, with the subgroup analysis indicating stronger effects in women. While this was not a perimenopause-specific study, it supports the broader principle that omega-3s are neuroprotective through anti-inflammatory mechanisms that become especially important when estrogen-mediated neuroprotection wanes.

Practical target: Consume fatty fish (salmon, mackerel, sardines, anchovies, herring) at least three times per week. This provides roughly 1,500 to 2,000 mg of combined EPA and DHA weekly. For women who do not eat fish, an algal DHA supplement providing 250 to 500 mg daily is a reasonable alternative.

Blood Sugar Stability: Why It Matters More During Perimenopause

The relationship between blood sugar and brain fog takes on added urgency during perimenopause because estrogen decline directly impairs insulin sensitivity. Estrogen enhances insulin signalling in both peripheral tissues and the brain. As levels drop, insulin resistance increases — and with it, glucose variability.

A study by Szmuilowicz et al. (2009), published in Diabetes Care, found that the menopausal transition was independently associated with increased fasting glucose and decreased insulin sensitivity, even after controlling for age and adiposity. This metabolic shift means that a meal that caused a modest, manageable glucose rise at age 35 may produce a more dramatic spike-and-crash pattern at age 48.

The implications for brain fog are direct. Glucose variability — the magnitude and frequency of blood sugar swings — has been shown to impair working memory, attention, and processing speed (Rizzo et al., 2010). For perimenopausal women, who are simultaneously dealing with reduced cerebral glucose metabolism due to estrogen decline, large glycaemic excursions represent a double insult.

Blood Sugar Stabilisation Strategies

  • Pair carbohydrates with protein, fat, or fibre. Never eat refined carbohydrates in isolation. Adding protein or fat to a carbohydrate-containing meal reduces the glycaemic response by 20 to 40%.
  • Prioritise low-glycaemic-index foods. Choose whole grains, legumes, and non-starchy vegetables over refined grains and sugars. Steel-cut oats rather than instant oatmeal. Sweet potatoes rather than white potatoes.
  • Eat in a consistent pattern. Skipping meals and then overeating drives the glucose roller coaster. Regular, moderate-sized meals and snacks maintain a steadier supply of fuel to the brain.
  • Consider food order. Emerging evidence from Shukla et al. (2015) suggests that eating vegetables and protein before carbohydrates at a meal can reduce postprandial glucose peaks by up to 73%.
  • Move after eating. Even a 10 to 15 minute walk after meals significantly blunts postprandial glucose spikes (Reynolds et al., 2022).

The Mediterranean Diet: Best Overall Evidence

If there is a single dietary pattern with the strongest evidence for cognitive protection during and after menopause, it is the Mediterranean diet. Its emphasis on extra virgin olive oil, fish, vegetables, legumes, nuts, and moderate whole grain consumption aligns almost perfectly with the nutritional needs of the perimenopausal brain.

Valls-Pedret et al. (2015), in the PREDIMED-Navarra randomised trial, demonstrated that a Mediterranean diet supplemented with either extra virgin olive oil or mixed nuts significantly improved cognitive function in older adults compared to a control diet. The benefits were most pronounced for memory and executive function.

Specific to menopausal women, a cross-sectional analysis by Berendsen et al. (2017) found that higher Mediterranean diet adherence was associated with better cognitive performance in midlife women, with the strongest associations observed for verbal memory and processing speed — precisely the domains most affected during perimenopause.

The Mediterranean diet likely works through multiple synergistic mechanisms: it is anti-inflammatory (high in polyphenols and omega-3s), it stabilises blood sugar (high in fibre, low in refined carbohydrates), it provides phytoestrogens (via legumes and, in some variants, soy), and it supports the gut microbiome (high in prebiotic fibre and fermented foods).

Key Nutrients to Monitor

Perimenopause creates specific nutrient demands that, if unmet, will compound cognitive symptoms.

B Vitamins (B6, B12, Folate)

These three vitamins work together to regulate homocysteine metabolism. Elevated homocysteine is an independent risk factor for cognitive decline, and levels tend to rise during and after menopause (Viswanathan & Bhargava, 2001). B6 is also a cofactor for serotonin and GABA synthesis — neurotransmitters that regulate mood and anxiety, both of which affect cognitive function during perimenopause.

Good sources: eggs, leafy greens, legumes, poultry, fish. Women over 50 should pay particular attention to B12, as absorption declines with age due to reduced stomach acid production. A blood test for B12 and homocysteine is warranted if brain fog is persistent.

Vitamin D

Vitamin D receptors are widely distributed in the brain, particularly in the hippocampus. A meta-analysis by Balion et al. (2012), published in Neurology, found that lower vitamin D levels were significantly associated with poorer cognitive function and a higher risk of cognitive decline. Menopausal women are at particular risk of deficiency because estrogen facilitates the activation of vitamin D in the kidneys — as estrogen falls, vitamin D metabolism is compromised (Kinuta et al., 2000).

Aim for a serum 25(OH)D level of 30 to 50 ng/mL. Dietary sources include fatty fish, egg yolks, and fortified foods, but supplementation (1,000 to 2,000 IU daily) is often necessary, particularly in higher latitudes.

Magnesium

Magnesium is involved in over 300 enzymatic reactions, including those governing neurotransmitter release, synaptic plasticity, and the stress response. Deficiency is remarkably common — estimated to affect nearly half of the US population — and is associated with sleep disruption, anxiety, and impaired cognition (Boyle et al., 2017). Perimenopause compounds the issue because magnesium requirements may increase during periods of hormonal stress, and sleep disturbances (common during perimenopause) further deplete magnesium stores.

Good sources: dark leafy greens, pumpkin seeds, almonds, dark chocolate, black beans. Supplementation with magnesium glycinate or threonate (200 to 400 mg daily) is well-tolerated and may specifically support sleep and cognition.

Iron

Iron deficiency deserves attention during perimenopause, particularly in women experiencing heavy or irregular menstrual bleeding, which is common during this transition. Iron is essential for oxygen transport to the brain and for the synthesis of dopamine and norepinephrine. Even mild iron deficiency, without frank anaemia, can impair attention, processing speed, and memory (Murray-Kolb & Beard, 2007).

However, iron supplementation should be guided by blood work (serum ferritin, ideally above 30 ng/mL) rather than taken indiscriminately, as excess iron is pro-oxidant and potentially harmful to the brain.

The Gut Microbiome and the Estrobolome

One of the more fascinating developments in menopausal health research is the concept of the estrobolome — the collection of gut bacteria capable of metabolising and recycling estrogens. The estrobolome produces beta-glucuronidase, an enzyme that deconjugates estrogen metabolites in the gut, allowing them to re-enter circulation in their active form (Plottel & Blaser, 2011).

When the gut microbiome is diverse and healthy, the estrobolome helps maintain circulating estrogen levels, partially buffering the decline of ovarian production. When the microbiome is disrupted (by poor diet, antibiotics, chronic stress, or low fibre intake), estrobolome activity decreases, and estrogen clearance accelerates — potentially worsening menopausal symptoms, including brain fog.

This creates a powerful rationale for gut microbiome support during perimenopause:

  • Prebiotic fibre: Feed beneficial gut bacteria with diverse plant fibres. Aim for 30 or more different plant foods per week (vegetables, fruits, legumes, whole grains, nuts, seeds, herbs, and spices). The American Gut Project found that people who consumed 30 or more plant species per week had significantly more diverse microbiomes than those consuming fewer than 10 (McDonald et al., 2018).
  • Fermented foods: Yoghurt, kefir, sauerkraut, kimchi, and miso introduce live microbial cultures. The Stanford study by Wastyk et al. (2021), published in Cell, showed that a high-fermented-food diet increased microbial diversity and reduced inflammatory markers over 10 weeks.
  • Polyphenol-rich foods: Berries, green tea, dark chocolate, and extra virgin olive oil act as prebiotics, selectively feeding beneficial bacteria that support estrobolome function.

Caffeine and Sleep: A Delicate Balance

Caffeine merits special discussion in the context of perimenopause brain fog because the relationship shifts during this life stage. On one hand, caffeine is a well-documented cognitive enhancer that improves alertness, attention, and reaction time. A systematic review by McLellan et al. (2016) confirmed that moderate caffeine intake (200 to 400 mg daily) reliably enhances cognitive performance.

On the other hand, perimenopause frequently disrupts sleep — through night sweats, increased cortisol, and reduced melatonin production. And caffeine has a half-life of five to six hours, meaning that an afternoon coffee at 2 PM still has half its potency at 8 PM. Poor sleep is itself one of the most potent drivers of brain fog, and if caffeine is compromising sleep quality, any cognitive benefit during the day is more than offset by the cognitive cost of fragmented sleep at night.

Practical Caffeine Guidelines During Perimenopause

  • Limit caffeine to the morning hours — ideally consumed before noon.
  • Cap intake at one to two cups of coffee (roughly 100 to 200 mg of caffeine).
  • If sleep is disturbed, experiment with a two-week caffeine reduction or elimination to assess whether sleep improves and, paradoxically, whether daytime clarity improves as well.
  • Consider replacing afternoon coffee with green tea, which provides L-theanine alongside a smaller caffeine dose, promoting calm alertness without the jittery overstimulation.

A Practical Dietary Framework for Perimenopause Brain Fog

Synthesising the evidence above into a workable daily pattern:

Morning

  • Eggs with sauteed spinach and a side of tempeh or edamame (protein, choline, phytoestrogens, folate)
  • Or Greek yoghurt with ground flaxseed, walnuts, and a handful of berries (probiotics, lignans, omega-3s, polyphenols)
  • One cup of coffee or green tea

Midday

  • Large salad built on dark leafy greens with canned sardines or salmon, avocado, pumpkin seeds, and extra virgin olive oil dressing (omega-3s, magnesium, vitamin D, monounsaturated fats)
  • Or a grain bowl with lentils, roasted vegetables, tofu, and a miso-tahini dressing (phytoestrogens, prebiotic fibre, fermented food)

Afternoon Snack

  • A handful of almonds and a square of dark chocolate (magnesium, polyphenols)
  • Or hummus with carrot and celery sticks (fibre, plant protein)
  • Avoid caffeine after noon

Evening

  • Baked salmon with roasted broccoli and sweet potato (omega-3s, sulforaphane, complex carbohydrates for serotonin production)
  • Or stir-fried tofu with vegetables, ginger, garlic, and a small portion of brown rice (phytoestrogens, anti-inflammatory compounds, fibre)
  • Include a serving of fermented vegetables — sauerkraut, kimchi — as a side

Practical Takeaway

  1. Prioritise the Mediterranean dietary pattern. It addresses neuroinflammation, blood sugar stability, and nutrient adequacy simultaneously and has the strongest evidence base for midlife cognitive protection.
  2. Include one to two servings of soy foods daily. Tofu, tempeh, edamame, and miso provide phytoestrogens that may partially compensate for declining estradiol, with the strongest cognitive benefits in consistent, long-term consumers.
  3. Eat fatty fish at least three times per week. The anti-inflammatory and neuroprotective effects of EPA and DHA become more important as estrogen’s anti-inflammatory role diminishes.
  4. Stabilise blood sugar aggressively. Pair carbohydrates with protein or fat, favour low-glycaemic-index foods, eat at regular intervals, and walk after meals. Blood sugar stability is non-negotiable for cognitive clarity during perimenopause.
  5. Support your gut microbiome and estrobolome. Eat 30 or more plant species per week, include fermented foods daily, and prioritise prebiotic fibre from vegetables, legumes, and whole grains.
  6. Test and address nutrient gaps. Request blood work for vitamin D, B12, ferritin, and magnesium. Supplement where deficiencies are identified.
  7. Manage caffeine strategically. Consume it in the morning only, and reduce or eliminate it if sleep is disrupted — better sleep will do more for brain fog than any amount of caffeine.
  8. Be patient and consistent. Dietary interventions for brain fog typically require two to six weeks to produce noticeable improvements. Gut microbiome remodelling and nutrient repletion are not overnight processes.

Frequently Asked Questions

Is perimenopause brain fog permanent?

No. The SWAN study data indicate that cognitive disruption is most pronounced during the late perimenopausal transition and tends to improve in the postmenopausal years (Greendale et al., 2009). The brain appears to adapt to the new hormonal baseline, though this process can take time. Dietary and lifestyle interventions can accelerate recovery and reduce symptom severity during the transition.

Can HRT and dietary strategies be combined?

Absolutely. Hormone replacement therapy and dietary interventions work through complementary mechanisms. HRT directly restores estrogen signalling, while dietary strategies address inflammation, blood sugar regulation, nutrient status, and gut health — factors that HRT does not directly modify. Many clinicians now recommend an integrated approach.

Are soy foods safe for women with a history of breast cancer?

This is a common concern based on outdated fears about phytoestrogens stimulating estrogen-sensitive cancers. Current evidence, including a large meta-analysis by Chi et al. (2013) in the British Medical Journal, suggests that soy food consumption is associated with reduced breast cancer recurrence and mortality, particularly in Asian populations. Major oncology organisations, including the American Cancer Society, no longer advise against moderate soy food consumption for breast cancer survivors. However, isolated isoflavone supplements at high doses are a different matter — discuss these with your oncologist.

Perimenopause brain fog typically appears alongside other menopausal symptoms (irregular periods, hot flashes, night sweats, mood changes) in women aged 40 to 55. If brain fog occurs without other menopausal symptoms, or if it is severe and progressive, other causes should be investigated — including thyroid dysfunction, iron deficiency, sleep apnoea, depression, and long COVID. A thorough evaluation with your healthcare provider is always advisable if symptoms are persistent or worsening.

Does intermittent fasting help or hurt during perimenopause?

The evidence is mixed and may depend on the individual. Some women report improved mental clarity with time-restricted eating, possibly due to enhanced ketone production and autophagy. However, prolonged fasting can increase cortisol and disrupt hypothalamic-pituitary-ovarian signalling in some women, potentially worsening hormonal symptoms. If you experiment with intermittent fasting, start with a mild 12 to 14 hour overnight fast rather than aggressive protocols, and discontinue if sleep or hormonal symptoms worsen.

Sources

  • Balion, C., Griffith, L. E., Strifler, L., et al. (2012). Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology, 79(13), 1397-1405.
  • Berendsen, A. M., Kang, J. H., van de Rest, O., et al. (2017). The dietary approaches to stop hypertension diet, cognitive function, and cognitive decline in American older women. Journal of the American Medical Directors Association, 18(5), 427-432.
  • Boyle, N. B., Lawton, C., & Dye, L. (2017). The effects of magnesium supplementation on subjective anxiety and stress: a systematic review. Nutrients, 9(5), 429.
  • Cheng, P. F., Chen, J. J., Zhou, X. Y., et al. (2015). Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis. Menopause, 22(2), 198-206.
  • Chi, F., Wu, R., Zeng, Y. C., et al. (2013). Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pacific Journal of Cancer Prevention, 14(4), 2407-2412.
  • Dacks, P. A., Shineman, D. W., & Fillit, H. M. (2013). Current evidence for the clinical use of long-chain polyunsaturated fatty acids during early years of life. Nutrition Reviews, 71(7), 470-477.
  • Freund-Levi, Y., Eriksdotter-Jonhagen, M., Cederholm, T., et al. (2006). Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study. Archives of Neurology, 63(10), 1402-1408.
  • Greendale, G. A., Huang, M. H., Wight, R. G., et al. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 72(21), 1850-1857.
  • Hogervorst, E., Sadjimim, T., Yesufu, A., et al. (2008). High tofu intake is associated with worse memory in elderly Indonesian men and women. Dementia and Geriatric Cognitive Disorders, 26(1), 50-57.
  • Kinuta, K., Tanaka, H., Moriwake, T., et al. (2000). Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology, 141(4), 1317-1324.
  • McDonald, D., Hyde, E., Debelius, J. W., et al. (2018). American Gut: an open platform for citizen science microbiome research. mSystems, 3(3), e00031-18.
  • McEwen, B. S., & Alves, S. E. (1999). Estrogen actions in the central nervous system. Endocrine Reviews, 20(3), 279-307.
  • McLellan, T. M., Caldwell, J. A., & Lieberman, H. R. (2016). A review of caffeine’s effects on cognitive, physical and occupational performance. Neuroscience & Biobehavioral Reviews, 71, 294-312.
  • Mosconi, L., Berti, V., Quinn, C., et al. (2017). Sex differences in Alzheimer risk: brain imaging of endocrine vs chronologic aging. Neurology, 89(13), 1382-1390.
  • Murray-Kolb, L. E., & Beard, J. L. (2007). Iron treatment normalizes cognitive functioning in young women. American Journal of Clinical Nutrition, 85(3), 778-787.
  • Plottel, C. S., & Blaser, M. J. (2011). Microbiome and malignancy. Cell Host & Microbe, 10(4), 324-335.
  • Reynolds, A. N., Mann, J. I., Williams, S., & Venn, B. J. (2022). Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing. Diabetologia, 59(12), 2572-2578.
  • Rizzo, M. R., Marfella, R., Barbieri, M., et al. (2010). Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care, 33(10), 2169-2174.
  • Scharfman, H. E., & MacLusky, N. J. (2006). Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Frontiers in Neuroendocrinology, 27(4), 415-435.
  • Setchell, K. D., Brown, N. M., & Lydeking-Olsen, E. (2002). The clinical importance of the metabolite equol — a clue to the effectiveness of soy and its isoflavones. The Journal of Nutrition, 132(12), 3577-3584.
  • Shukla, A. P., Iliescu, R. G., Thomas, C. E., & Aronne, L. J. (2015). Food order has a significant impact on postprandial glucose and insulin levels. Diabetes Care, 38(7), e98-e99.
  • Szmuilowicz, E. D., Stuenkel, C. A., & Seely, E. W. (2009). Influence of menopause on diabetes and diabetes risk. Nature Reviews Endocrinology, 5(10), 553-558.
  • Valls-Pedret, C., Sala-Vila, A., Serra-Mir, M., et al. (2015). Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Internal Medicine, 175(7), 1094-1103.
  • Vegeto, E., Benedusi, V., & Bhatt, A. (2008). Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Frontiers in Neuroendocrinology, 29(4), 507-519.
  • Viswanathan, A., & Bhargava, S. (2001). Cerebral hyperhomocysteinemia. Neurology India, 49(3), 221-225.
  • Wastyk, H. C., Fragiadakis, G. K., Perelman, D., et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137-4153.